Chemical Synthesis Laboratory (SB-ISIC-LSYNC), Swiss Federal Institute of Technology (EPFL), CH-1015 Lausanne, Switzerland.
J Am Chem Soc. 2010 Feb 3;132(4):1432-42. doi: 10.1021/ja9097093.
The preparation of the polyketide natural products anguinomycin C and D is reported based on key steps such as Negishi stereoinversion cross coupling, Jacobsen Cr(III)-catalyzed Hetero Diels-Alder reaction, Evans B-mediated syn-aldol chemistry, and B-alkyl Suzuki-Miyaura cross coupling. The configuration of both natural products was established as (5R,10R,16R,18S,19R,20S). Biological evaluation demonstrated that these natural products are inhibitors of the nuclear export receptor CRM1, leading to shutdown of CRM1-mediated nuclear protein export at concentrations above 10 nM. Analogues of anguinomycin and leptomycin B (LMB) have been prepared, and the simple alpha,beta-unsaturated lactone analogue 4 with a truncated polyketide chain retains most of the biological activity (inhibition above 25 nM). The structural basis for this inhibition has been demonstrated by modeling the transport inhibitors into X-ray crystal structures, thus highlighting key points for successful and strong biological action of anguinomycin and LMB.
聚酮天然产物anguinomycin C 和 D 的制备是基于 Negishi 立体反转交叉偶联、Jacobsen Cr(III)催化的杂 Diels-Alder 反应、Evans B 介导的 syn-aldol 化学和 B-烷基 Suzuki-Miyaura 交叉偶联等关键步骤。这两种天然产物的构型均被确定为 (5R,10R,16R,18S,19R,20S)。生物评价表明,这些天然产物是核输出受体 CRM1 的抑制剂,导致 CRM1 介导的核蛋白输出在浓度高于 10 nM 时关闭。已经制备了 anguinomycin 和 leptomycin B (LMB) 的类似物,并且具有截断聚酮链的简单α,β-不饱和内酯类似物 4 保留了大部分生物活性(抑制作用高于 25 nM)。通过将这些运输抑制剂建模到 X 射线晶体结构中,证明了这种抑制的结构基础,从而突出了 anguinomycin 和 LMB 成功和强烈生物作用的关键点。